Antagonist anti-CD40 antibody CHIR-12.12 causes tumor regression and prolongs survival in multiple myeloma xenograft models.

被引：0
|
作者：
Long, L [1 ]
Tong, X [1 ]
Patawaran, M [1 ]
Aukerman, L [1 ]
Jallal, B [1 ]
Luqman, M [1 ]
机构：
[1] Chiron Corp, Emeryville, CA 94608 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.4888.4888
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4888
引用
收藏
页码：304B / 304B
页数：1
相关论文
共 50 条
  • [41] Cross-linking of CD40 using Anti-CD40 antibody, 5C11, had different effects on XG2 multiple myeloma cells.
    Qi, CJ
    Shi, HZ
    Shi, Q
    Gu, T
    Zhuang, YM
    Xi, H
    Zhang, ZX
    BLOOD, 2002, 100 (11) : 368B - 368B
  • [42] Anti-CD40 Monoclonal Antibody Synergizes with CTLA4-Ig in Promoting Long-Term Graft Survival in Murine Models of Transplantation
    Gilson, Christopher R.
    Milas, Zvonimir
    Gangappa, Shivaprakash
    Hollenbaugh, Diane
    Pearson, Thomas C.
    Ford, Mandy L.
    Larsen, Christian P.
    JOURNAL OF IMMUNOLOGY, 2009, 183 (03): : 1625 - 1635
  • [43] CFT7455: A novel, IKZF1/3 degrader that demonstrates potent tumor regression in IMiD-resistant multiple myeloma (MM) xenograft models.
    Henderson, James A.
    Kirby, R. Jason
    Perino, Samantha
    Agafonov, Roman V.
    Chaturvedi, Prasoon
    Class, Bradley
    Cocozziello, David
    Eron, Scott J.
    Good, Andrew
    Hart, Ashley A.
    Henderson, Christina
    Isasa, Marta
    Ladd, Brendon
    Schnaderbeck, Matt
    Mahler, Michelle
    Pollock, Roy M.
    Crystal, Adam S.
    Nasveschuk, Christopher G.
    Phillips, Andrew J.
    Fisher, Stewart L.
    Proia, David A.
    CANCER RESEARCH, 2021, 81 (13)
  • [44] RETRACTION: Mechanisms by which SGN-40, a Humanized Anti-CD40 Antibody, Induces Cytotoxicity in Human Multiple Myeloma Cells: Clinical Implications (Retraction of Vol 64, Pg 2846, 2004)
    Tai, Yu-Tzu
    Catley, Laurence P.
    Mitsiades, Constantine S.
    Burger, Renate
    Podar, Klaus
    Shringpaure, Reshma
    Hideshima, Teru
    Chauhan, Dharminder
    Hamasaki, Makoto
    Ishitsuka, Kenji
    Richardson, Paul
    Treon, Steven P.
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    CANCER RESEARCH, 2024, 84 (06) : 936 - 936
  • [45] Role of anti-CD40 antibody-mediated costimulation blockade on non-Gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig-to-baboon model
    Mohiuddin, Muhammad M.
    Singh, Avneesh K.
    Corcoran, Philip C.
    Hoyt, Robert F.
    Thomas, Marvin L., III
    Lewis, Billeta G. T.
    Eckhaus, Michael
    Dabkowski, Nicole L.
    Belli, Aaron J.
    Reimann, Keith A.
    Ayares, David
    Horvath, Keith A.
    XENOTRANSPLANTATION, 2014, 21 (01) : 35 - 45
  • [46] Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft
    Muhammad M. Mohiuddin
    Avneesh K. Singh
    Philip C. Corcoran
    Marvin L. Thomas III
    Tannia Clark
    Billeta G. Lewis
    Robert F. Hoyt
    Michael Eckhaus
    Richard N. Pierson III
    Aaron J. Belli
    Eckhard Wolf
    Nikolai Klymiuk
    Carol Phelps
    Keith A. Reimann
    David Ayares
    Keith A. Horvath
    Nature Communications, 7
  • [47] Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft
    Mohiuddin, Muhammad M.
    Singh, Avneesh K.
    Corcoran, Philip C.
    Thomas, Marvin L., III
    Clark, Tannia
    Lewis, Billeta G.
    Hoyt, Robert F.
    Eckhaus, Michael
    Pierson, Richard N., III
    Belli, Aaron J.
    Wolf, Eckhard
    Klymiuk, Nikolai
    Phelps, Carol
    Reimann, Keith A.
    Ayares, David
    Horvath, Keith A.
    NATURE COMMUNICATIONS, 2016, 7
  • [48] TAK-573, an anti-CD38-targeted attenuated interferon alpha (IFNα) fusion protein, showed anti-myeloma tumor responses in combination with standard of care (SOC) agents in multiple myeloma (MM) xenograft tumor models in vivo
    Fatholahi, Marjan
    Valencia, Miriam
    Mark, Armanini
    Bi, Mingying
    Syed, Sakeena
    Zhang, Yuhong
    Taura, Tetsuya
    Yun, Yong
    Wilson, David
    Chattopadhyay, Nibedita
    Bjorck, Pia
    Curley, Michael
    Sarah, Pogue
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E116 - E116
  • [49] An Fc-Engineered Humanized Anti-CD40 Monoclonal Antibody, XmAb5485, Exhibits Potent Activity in Vitro and in Vivo against Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma
    Zhukovsky, Eugene A.
    Horton, Holly
    Peipp, Matthias
    Pong, Erik
    Bernett, Matthew
    Karki, Sher
    Richards, John
    Chu, Seung
    Repp, Roland
    Desjarlais, John
    BLOOD, 2008, 112 (11) : 325 - 326
  • [50] A Humanized Anti-Ganglioside GM2 Antibody, BIW-8962, Exhibits ADCC/CDC Activity against Multiple Myeloma Cells and Potent Anti-Tumor Activity in Mouse Xenograft Models
    Ishi, Toshihiko
    Chanan-Khan, Asher Alban
    Jafferjee, Jazur
    Ersing, Noreen
    Takahashi, Takeshi
    Mizutani, Masato
    Shiotsu, Yukimasa
    Hanai, Nobuo
    BLOOD, 2008, 112 (11) : 605 - 605
12345